|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.44 EUR | +0.87% |
|
-1.07% | -4.35% |
| 11-25 | AKZO NOBEL NV : Receives a Buy rating from Barclays | ZD |
| 11-24 | Bernstein Downgrades Akzo Nobel to Market Perform, Reduces PT | MT |
| Capitalization | 9.48B 11.03B 8.88B 8.28B 15.29B 993B 16.63B 104B 40.12B 469B 41.4B 40.52B 1,714B | P/E ratio 2025 * |
20.8x | P/E ratio 2026 * | 13.5x |
|---|---|---|---|---|---|
| Enterprise value | 12.96B 15.08B 12.14B 11.32B 20.91B 1,357B 22.74B 142B 54.85B 641B 56.6B 55.4B 2,344B | EV / Sales 2025 * |
1.26x | EV / Sales 2026 * | 1.25x |
| Free-Float |
98.43% | Yield 2025 * |
3.62% | Yield 2026 * | 3.73% |
Last Transcript: Akzo Nobel N.V.
| 1 day | +0.87% | ||
| 1 week | -1.07% | ||
| Current month | -1.07% | ||
| 1 month | -1.91% | ||
| 3 months | -8.15% | ||
| 6 months | -5.20% | ||
| Current year | -4.35% |
| 1 week | 54.66 |  | 56.18 |
| 1 month | 52.02 | | 59.22 |
| Current year | 48.64 | | 63.5 |
| 1 year | 48.64 | | 63.5 |
| 3 years | 48.64 | | 79.32 |
| 5 years | 48.64 | | 108.45 |
| 10 years | 45.73 | | 108.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 31/10/2022 | |
Kenny Chae
IRC | Investor Relations Contact | - | 31/07/2021 |
| Corporate Officer/Principal | 58 | 31/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Van Bylen
BRD | Director/Board Member | 64 | 22/04/2022 |
Ester Baiget
BRD | Director/Board Member | 54 | 31/12/2021 |
Ben Noteboom
CHM | Chairman | 67 | 30/06/2023 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.6% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.87% | -1.07% | -5.55% | -16.33% | 11.03B | |
| -0.67% | -3.08% | -13.53% | +31.36% | 82.1B | |
| +0.38% | +3.27% | +21.05% | -5.97% | 31.64B | |
| +0.36% | +0.99% | -19.50% | -24.93% | 22.67B | |
| -0.35% | -1.23% | -4.10% | -14.57% | 15.15B | |
| +0.29% | -1.82% | -23.23% | +2.22% | 13.5B | |
| -0.57% | -2.32% | +14.41% | +6.63% | 7.16B | |
| -0.62% | -3.48% | -27.30% | +9.12% | 6.2B | |
| +0.02% | +5.63% | +37.84% | -24.71% | 4.87B | |
| -0.34% | -1.77% | +11.06% | +31.42% | 2.67B | |
| Average | -0.06% | -0.85% | -0.88% | -0.58% | 19.7B | |
| Weighted average by Cap. | -0.18% | -1.09% | -5.97% | +7.70% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.3B 11.98B 9.65B 8.99B 16.61B 1,079B 18.07B 113B 43.58B 509B 44.98B 44.02B 1,862B | 10.23B 11.9B 9.58B 8.93B 16.49B 1,071B 17.94B 112B 43.27B 506B 44.65B 43.7B 1,849B |
| Net income | 358M 416M 335M 312M 577M 37.45B 627M 3.92B 1.51B 17.69B 1.56B 1.53B 64.68B | 670M 780M 628M 585M 1.08B 70.15B 1.18B 7.34B 2.83B 33.13B 2.93B 2.86B 121B |
| Net Debt | 3.48B 4.05B 3.26B 3.04B 5.62B 365B 6.11B 38.15B 14.73B 172B 15.2B 14.88B 630B | 3.33B 3.87B 3.12B 2.91B 5.37B 348B 5.84B 36.47B 14.08B 165B 14.53B 14.22B 602B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 55.44 € | +0.87% | 632,757 |
| 04/12/25 | 54.96 € | -0.40% | 643,073 |
| 03/12/25 | 55.18 € | -0.22% | 474,782 |
| 02/12/25 | 55.30 € | -0.79% | 398,576 |
| 01/12/25 | 55.74 € | -0.54% | 434,851 |
Real-time Euronext Amsterdam, December 05, 2025 at 04:55 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AKZA Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition